Skip to main content
Top
Published in: Critical Care 4/2014

Open Access 01-08-2014 | Viewpoint

Tranexamic acid in pediatric trauma: why not?

Authors: Suzanne Beno, Alun D Ackery, Jeannie Callum, Sandro Rizoli

Published in: Critical Care | Issue 4/2014

Login to get access

Abstract

Trauma is a leading cause of death in pediatrics. Currently, no medical treatment exists to reduce mortality in the setting of pediatric trauma; however, this evidence does exist in adults. Bleeding and coagulopathy after trauma increases mortality in both adults and children. Clinical research has demonstrated a reduction in mortality with early use of tranexamic acid in adult trauma patients in both civilian and military settings. Tranexamic acid used in the perioperative setting safely reduces transfusion requirements in children. This article compares the hematologic response to trauma between children and adults, and explores the potential use of tranexamic acid in pediatric hemorrhagic trauma.
Literature
1.
go back to reference American Academy of Pediatrics, Pediatric Orthopedic Society of North America: Policy statement: management of pediatric trauma. Pediatrics. 2008, 121: 849-854.CrossRef American Academy of Pediatrics, Pediatric Orthopedic Society of North America: Policy statement: management of pediatric trauma. Pediatrics. 2008, 121: 849-854.CrossRef
2.
go back to reference Dzik WH, Blajchman MA, Fergusson D, Hameed M, Henry B, Kirkpatrick AW, Korogyi T, Logsetty S, Skeate RC, Stanworth S, MacAdams C, Muirhead B: Clinical review: Canadian National Advisory Committee on Blood and Blood Products - massive Transfusion Consensus Conference 2011: report of the panel. Crit Care. 2011, 15: 242-10.1186/cc10498.PubMedCentralCrossRefPubMed Dzik WH, Blajchman MA, Fergusson D, Hameed M, Henry B, Kirkpatrick AW, Korogyi T, Logsetty S, Skeate RC, Stanworth S, MacAdams C, Muirhead B: Clinical review: Canadian National Advisory Committee on Blood and Blood Products - massive Transfusion Consensus Conference 2011: report of the panel. Crit Care. 2011, 15: 242-10.1186/cc10498.PubMedCentralCrossRefPubMed
3.
go back to reference Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejia-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S, CRASH-2 trial collaborators: Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010, 376: 23-32.CrossRefPubMed Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejia-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S, CRASH-2 trial collaborators: Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010, 376: 23-32.CrossRefPubMed
4.
go back to reference Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ: Military application of tranexamic acid in trauma emergency resuscitation (MATTERS) study. Arch Surg. 2012, 147: 113-119. 10.1001/archsurg.2011.287.CrossRefPubMed Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ: Military application of tranexamic acid in trauma emergency resuscitation (MATTERS) study. Arch Surg. 2012, 147: 113-119. 10.1001/archsurg.2011.287.CrossRefPubMed
5.
go back to reference Okamoto S, Hijikata-Okunomiya A, Wanaka K, Okada Y, Okamoto U: Enzyme controlling medicines: introduction. Semin Thromb Hemost. 1997, 23: 493-501. 10.1055/s-2007-996127.CrossRefPubMed Okamoto S, Hijikata-Okunomiya A, Wanaka K, Okada Y, Okamoto U: Enzyme controlling medicines: introduction. Semin Thromb Hemost. 1997, 23: 493-501. 10.1055/s-2007-996127.CrossRefPubMed
6.
go back to reference Henry D, Carless P, Fergusson D, Laupacis A: The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. CMAJ. 2009, 180: 183-193. 10.1503/cmaj.081109.PubMedCentralCrossRefPubMed Henry D, Carless P, Fergusson D, Laupacis A: The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. CMAJ. 2009, 180: 183-193. 10.1503/cmaj.081109.PubMedCentralCrossRefPubMed
7.
go back to reference Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W: Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res. 2009, 123: 687-696. 10.1016/j.thromres.2008.09.015.CrossRefPubMed Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W: Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res. 2009, 123: 687-696. 10.1016/j.thromres.2008.09.015.CrossRefPubMed
8.
go back to reference Naoulou B, Tsai MC: Efficacy of tranexamic acid in the treatment of idiopathic and non-functional heavy menstrual bleeding: a systematic review. Acta Obstet Gynecol Scand. 2012, 91: 529-537. 10.1111/j.1600-0412.2012.01361.x.CrossRefPubMed Naoulou B, Tsai MC: Efficacy of tranexamic acid in the treatment of idiopathic and non-functional heavy menstrual bleeding: a systematic review. Acta Obstet Gynecol Scand. 2012, 91: 529-537. 10.1111/j.1600-0412.2012.01361.x.CrossRefPubMed
9.
go back to reference Gluud LL, Klingenberg SL, Langholz SE: Systematic review: tranexamic acid for upper gastrointestinal bleeding. Aliment Pharmacol Ther. 2008, 27: 752-758. 10.1111/j.1365-2036.2008.03638.x.CrossRefPubMed Gluud LL, Klingenberg SL, Langholz SE: Systematic review: tranexamic acid for upper gastrointestinal bleeding. Aliment Pharmacol Ther. 2008, 27: 752-758. 10.1111/j.1365-2036.2008.03638.x.CrossRefPubMed
10.
go back to reference Raza I, Davenport R, Rourke C, Platton S, Manson J, Spoors C, Khan S, De’Ath HD, Allard S, Hart DP, Pasi KJ, Hunt BJ, Stanworth S, MacCallum PK, Brohi K: The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost. 2013, 11: 307-314. 10.1111/jth.12078.CrossRefPubMed Raza I, Davenport R, Rourke C, Platton S, Manson J, Spoors C, Khan S, De’Ath HD, Allard S, Hart DP, Pasi KJ, Hunt BJ, Stanworth S, MacCallum PK, Brohi K: The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost. 2013, 11: 307-314. 10.1111/jth.12078.CrossRefPubMed
11.
go back to reference Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T, CRASH-2 trial collaborators: The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011, 377: 1096-1101.CrossRefPubMed Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T, CRASH-2 trial collaborators: The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011, 377: 1096-1101.CrossRefPubMed
12.
go back to reference Murkin JM, Falter F, Granton J, Young B, Burt C, Chu M: High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg. 2010, 110: 350-353. 10.1213/ANE.0b013e3181c92b23.CrossRefPubMed Murkin JM, Falter F, Granton J, Young B, Burt C, Chu M: High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg. 2010, 110: 350-353. 10.1213/ANE.0b013e3181c92b23.CrossRefPubMed
13.
go back to reference Kalavrouziotis D, Voisine P, Mohammadi S, Dionne S, Dagenais F: High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass. Ann Thorac Surg. 2012, 93: 148-154. 10.1016/j.athoracsur.2011.07.085.CrossRefPubMed Kalavrouziotis D, Voisine P, Mohammadi S, Dionne S, Dagenais F: High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass. Ann Thorac Surg. 2012, 93: 148-154. 10.1016/j.athoracsur.2011.07.085.CrossRefPubMed
14.
go back to reference Manji RA, Grocott HP, Leake J, Ariano RE, Manji JS, Menkis AH, Jacobsohn E: Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors. Can J Anaesth. 2012, 59: 6-13. 10.1007/s12630-011-9618-z.CrossRefPubMed Manji RA, Grocott HP, Leake J, Ariano RE, Manji JS, Menkis AH, Jacobsohn E: Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors. Can J Anaesth. 2012, 59: 6-13. 10.1007/s12630-011-9618-z.CrossRefPubMed
15.
go back to reference Koster A, Borgermann J, Zittermann A, Lueth JU, Gillis-Januszewski T, Schirmer U: Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: incidence and clinical outcome. Br J Anaesth. 2012, 59: 6-13. Koster A, Borgermann J, Zittermann A, Lueth JU, Gillis-Januszewski T, Schirmer U: Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: incidence and clinical outcome. Br J Anaesth. 2012, 59: 6-13.
16.
go back to reference Trauma and severe bleeding. Tranexamic acid within one hour to reduce mortality. Prescrire Int. 2013, 22: 189-190. Trauma and severe bleeding. Tranexamic acid within one hour to reduce mortality. Prescrire Int. 2013, 22: 189-190.
17.
go back to reference Ross J, Salman RA: The frequency of thrombotic events among adults given antifibrinolytic drugs for spontaneous bleeding: systematic review and meta-analysis of observational studies and randomized trials. Curr Drug Saf. 2012, 7: 44-54. 10.2174/157488612800492744.CrossRefPubMed Ross J, Salman RA: The frequency of thrombotic events among adults given antifibrinolytic drugs for spontaneous bleeding: systematic review and meta-analysis of observational studies and randomized trials. Curr Drug Saf. 2012, 7: 44-54. 10.2174/157488612800492744.CrossRefPubMed
18.
go back to reference Pretel IM, Marques ML, Aguado GL, Idoate Gastearena MA: Tranexamic acid-induced toxic epidermal necrolysis. Ann Pharmacother. 2013, 47: e16-10.1345/aph.1R637.CrossRef Pretel IM, Marques ML, Aguado GL, Idoate Gastearena MA: Tranexamic acid-induced toxic epidermal necrolysis. Ann Pharmacother. 2013, 47: e16-10.1345/aph.1R637.CrossRef
19.
go back to reference Ker K, Edwards P, Perel P, Shakur H, Roberts I: Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012, 344: e3054-10.1136/bmj.e3054.PubMedCentralCrossRefPubMed Ker K, Edwards P, Perel P, Shakur H, Roberts I: Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012, 344: e3054-10.1136/bmj.e3054.PubMedCentralCrossRefPubMed
20.
go back to reference Henry DA, Carless PA, Moxey AJ, O’Connell D, Stokes BJ, Fergusson DA, Ker K: Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2011, 3: CD001886-PubMed Henry DA, Carless PA, Moxey AJ, O’Connell D, Stokes BJ, Fergusson DA, Ker K: Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2011, 3: CD001886-PubMed
21.
go back to reference Faraoni D, Goobie SM: The efficacy of antifibrinolytic drugs in children undergoing noncardiac surgery: a systematic review of the literature. Anesth Analg. 2014, 118: 628-636. 10.1213/ANE.0000000000000080.CrossRefPubMed Faraoni D, Goobie SM: The efficacy of antifibrinolytic drugs in children undergoing noncardiac surgery: a systematic review of the literature. Anesth Analg. 2014, 118: 628-636. 10.1213/ANE.0000000000000080.CrossRefPubMed
22.
go back to reference Ker K, Junko K, Perel P, Edwards P, Shakur H, Roberts I: Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial. BMC Emerg Med. 2012, 12: 3-10.1186/1471-227X-12-3.PubMedCentralCrossRefPubMed Ker K, Junko K, Perel P, Edwards P, Shakur H, Roberts I: Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial. BMC Emerg Med. 2012, 12: 3-10.1186/1471-227X-12-3.PubMedCentralCrossRefPubMed
23.
go back to reference Pusateri AE, Weiskopf RB, Bebarta V, Butler F, Cestero RF, Chaudry IH, Deal V, Dorlac WC, Gerhardt RT, Given MB, Hansen DR, Hoots WK, Klein HG, Macdonald VW, Mattox KL, Michael RA, Mogford J, Montcalm-Smith EA, Niemeyer DM, Prusaczyk WK, Rappold JF, Rassmussen T, Rentas F, Ross J, Thompson C, Tucker LD, US DoD Hemorrhage and Resuscitation Research and Development Steering Committee: Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities. Shock. 2013, 39: 121-126. 10.1097/SHK.0b013e318280409a.CrossRefPubMed Pusateri AE, Weiskopf RB, Bebarta V, Butler F, Cestero RF, Chaudry IH, Deal V, Dorlac WC, Gerhardt RT, Given MB, Hansen DR, Hoots WK, Klein HG, Macdonald VW, Mattox KL, Michael RA, Mogford J, Montcalm-Smith EA, Niemeyer DM, Prusaczyk WK, Rappold JF, Rassmussen T, Rentas F, Ross J, Thompson C, Tucker LD, US DoD Hemorrhage and Resuscitation Research and Development Steering Committee: Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities. Shock. 2013, 39: 121-126. 10.1097/SHK.0b013e318280409a.CrossRefPubMed
24.
go back to reference Guerriero C, Cairns J, Perel P, Shakur H, Roberts I: Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS One. 2011, 6: e18987-10.1371/journal.pone.0018987.PubMedCentralCrossRefPubMed Guerriero C, Cairns J, Perel P, Shakur H, Roberts I: Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS One. 2011, 6: e18987-10.1371/journal.pone.0018987.PubMedCentralCrossRefPubMed
25.
go back to reference Dewan Y, Komolafe EO, Mejia-Mantilla JH, Perel P, Roberts I, Shakur H, CRASH-3 Collaborators: CRASH-3-tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial. Trials. 2012, 13: 87-10.1186/1745-6215-13-87.PubMedCentralCrossRefPubMed Dewan Y, Komolafe EO, Mejia-Mantilla JH, Perel P, Roberts I, Shakur H, CRASH-3 Collaborators: CRASH-3-tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial. Trials. 2012, 13: 87-10.1186/1745-6215-13-87.PubMedCentralCrossRefPubMed
26.
go back to reference Basta MN, Stricker PA, Taylor JA: A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. Pediatr Surg Int. 2012, 28: 1059-1069. 10.1007/s00383-012-3167-6.CrossRefPubMed Basta MN, Stricker PA, Taylor JA: A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. Pediatr Surg Int. 2012, 28: 1059-1069. 10.1007/s00383-012-3167-6.CrossRefPubMed
27.
go back to reference McLeod LM, French B, Flynn JM, Dormans JP, Keren R: Antifibrinolytic use and blood transfusions in pediatric scoliosis surgeries performed at US children’s hospitals. J Spinal Disord Tech. 2013, [Epub ahead of print] McLeod LM, French B, Flynn JM, Dormans JP, Keren R: Antifibrinolytic use and blood transfusions in pediatric scoliosis surgeries performed at US children’s hospitals. J Spinal Disord Tech. 2013, [Epub ahead of print]
28.
go back to reference Grassin-Delyle S, Couturier R, Abe E, Alvarez JC, Devillier P, Urien S: A practical tranexamic acid dosing scheme based on population pharmacokinetics in children undergoing cardiac surgery. Anesthesiology. 2013, 118: 853-862. 10.1097/ALN.0b013e318283c83a.CrossRefPubMed Grassin-Delyle S, Couturier R, Abe E, Alvarez JC, Devillier P, Urien S: A practical tranexamic acid dosing scheme based on population pharmacokinetics in children undergoing cardiac surgery. Anesthesiology. 2013, 118: 853-862. 10.1097/ALN.0b013e318283c83a.CrossRefPubMed
29.
go back to reference Albiani DA, Hodge WG, Pan YI, Urton TE, Clarke WN: Tranexamic acid in the treatment of pediatric traumatic hyphema. Can J Opthalmol. 2008, 43: 428-431. 10.3129/i08-066.CrossRef Albiani DA, Hodge WG, Pan YI, Urton TE, Clarke WN: Tranexamic acid in the treatment of pediatric traumatic hyphema. Can J Opthalmol. 2008, 43: 428-431. 10.3129/i08-066.CrossRef
30.
go back to reference Kauvar DS, Lefering R, Wade CE: Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006, 60: S3-S11. 10.1097/01.ta.0000199961.02677.19.CrossRefPubMed Kauvar DS, Lefering R, Wade CE: Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006, 60: S3-S11. 10.1097/01.ta.0000199961.02677.19.CrossRefPubMed
31.
go back to reference Mitra B, Cameron PA, Mori A, Fitzgerald M: Acute coagulopathy and early deaths post major trauma. Injury. 2012, 43: 22-25. 10.1016/j.injury.2010.10.015.CrossRefPubMed Mitra B, Cameron PA, Mori A, Fitzgerald M: Acute coagulopathy and early deaths post major trauma. Injury. 2012, 43: 22-25. 10.1016/j.injury.2010.10.015.CrossRefPubMed
32.
go back to reference Talving P, Lustenberger T, Lam L, Inaba K, Mohseni S, Plurad D, Green DJ, Demetriades D: Coagulopathy after isolated severe traumatic brain injury in children. J Trauma. 2011, 71: 1205-1210. 10.1097/TA.0b013e31820d151d.CrossRefPubMed Talving P, Lustenberger T, Lam L, Inaba K, Mohseni S, Plurad D, Green DJ, Demetriades D: Coagulopathy after isolated severe traumatic brain injury in children. J Trauma. 2011, 71: 1205-1210. 10.1097/TA.0b013e31820d151d.CrossRefPubMed
33.
go back to reference Peiniger S, Nienaber U, Lefering R, Braun M, Wafaisade A, Borgman MA, Spinella PC, Maegele M, Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie: Glasgow Coma Scale as a predictor for hemocoagulative disorders after blunt pediatric traumatic brain injury. Pediatr Crit Care Med. 2012, 13: 455-460. 10.1097/PCC.0b013e31823893c5.CrossRefPubMed Peiniger S, Nienaber U, Lefering R, Braun M, Wafaisade A, Borgman MA, Spinella PC, Maegele M, Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie: Glasgow Coma Scale as a predictor for hemocoagulative disorders after blunt pediatric traumatic brain injury. Pediatr Crit Care Med. 2012, 13: 455-460. 10.1097/PCC.0b013e31823893c5.CrossRefPubMed
34.
go back to reference Whittaker BW, Christiaans SC, Altice JL, Chen MK, Bartolucci AA, Morgan CJ, Kerby JD, Pittet JF: Early coagulopathy is an independent predictor of mortality in children after severe trauma. Shock. 2013, 39: 421-426. 10.1097/SHK.0b013e31828e08cb.PubMedCentralCrossRefPubMed Whittaker BW, Christiaans SC, Altice JL, Chen MK, Bartolucci AA, Morgan CJ, Kerby JD, Pittet JF: Early coagulopathy is an independent predictor of mortality in children after severe trauma. Shock. 2013, 39: 421-426. 10.1097/SHK.0b013e31828e08cb.PubMedCentralCrossRefPubMed
35.
go back to reference Holmes JF, Goodwin HC, Land C, Kuppermann N: Coagulation testing in pediatric blunt trauma patients. Pediatr Emerg Care. 2001, 17: 324-328. 10.1097/00006565-200110000-00002.CrossRefPubMed Holmes JF, Goodwin HC, Land C, Kuppermann N: Coagulation testing in pediatric blunt trauma patients. Pediatr Emerg Care. 2001, 17: 324-328. 10.1097/00006565-200110000-00002.CrossRefPubMed
36.
go back to reference Hendrickson JE, Shaz BH, Pereira G, Atkins E, Johnson KK, Bao G, Easley KA, Josephson CD: Coagulopathy is prevalent and associated with adverse outcomes in transfused pediatric trauma patients. J Pediatr. 2012, 160: 204-209. 10.1016/j.jpeds.2011.08.019.CrossRefPubMed Hendrickson JE, Shaz BH, Pereira G, Atkins E, Johnson KK, Bao G, Easley KA, Josephson CD: Coagulopathy is prevalent and associated with adverse outcomes in transfused pediatric trauma patients. J Pediatr. 2012, 160: 204-209. 10.1016/j.jpeds.2011.08.019.CrossRefPubMed
37.
go back to reference Patregnani JT, Borgman MA, Maegele M, Wade CE, Blackbourne LH, Spinella PC: Coagulopathy and shock on admission is associated with mortality for children with traumatic injuries at combat support hospitals. Pediatr Crit Care Med. 2012, 13: 273-277. 10.1097/PCC.0b013e31822f1727.CrossRefPubMed Patregnani JT, Borgman MA, Maegele M, Wade CE, Blackbourne LH, Spinella PC: Coagulopathy and shock on admission is associated with mortality for children with traumatic injuries at combat support hospitals. Pediatr Crit Care Med. 2012, 13: 273-277. 10.1097/PCC.0b013e31822f1727.CrossRefPubMed
38.
go back to reference Vogel AM, Radwin ZA, Cox CS, Cotton BA: Admission rapid thrombelastography delivers real-time ‘actionable’ data in pediatric trauma. J Ped Surg. 2013, 48: 1371-1376. 10.1016/j.jpedsurg.2013.03.036.CrossRef Vogel AM, Radwin ZA, Cox CS, Cotton BA: Admission rapid thrombelastography delivers real-time ‘actionable’ data in pediatric trauma. J Ped Surg. 2013, 48: 1371-1376. 10.1016/j.jpedsurg.2013.03.036.CrossRef
40.
go back to reference Harvey V, Perrone J, Kim P: Does the use of tranexamic acid improve trauma mortality?. Ann Emerg Med. 2013, pii: S0196-0644(13)01341-3- Harvey V, Perrone J, Kim P: Does the use of tranexamic acid improve trauma mortality?. Ann Emerg Med. 2013, pii: S0196-0644(13)01341-3-
Metadata
Title
Tranexamic acid in pediatric trauma: why not?
Authors
Suzanne Beno
Alun D Ackery
Jeannie Callum
Sandro Rizoli
Publication date
01-08-2014
Publisher
BioMed Central
Published in
Critical Care / Issue 4/2014
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc13965

Other articles of this Issue 4/2014

Critical Care 4/2014 Go to the issue